secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ardent Health, Inc. (ARDT)
CIK:        0001756655
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001628280-26-030552
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardent Health Q1 2026: Revenue $1.60B (+7%), Adjusted EBITDA $124M (+26%), Reaffirms FY Guidance
--------------------------------------------------------------------------------

- Total revenue $1.602B (+7.0% YoY); net income $40M ($0.28 diluted EPS) vs $41M ($0.29) a year ago.
- Adjusted EBITDA $124M (+26.3% YoY); excluding $10.9M gain, growth was 15%.
- Adjusted admissions +2.0%, total surgeries +1.2%; admissions -1.1% due to severe weather and light respiratory season.
- Reaffirmed FY2026 guidance: revenue $6.4–$6.7B, Adj EBITDA $485–$535M, diluted EPS $0.90–$1.27.
- Lease-adjusted net leverage improved to 2.6x from 3.0x a year ago; cash $610M, total debt $1.1B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/0001628280-26-030552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/ardt-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-030552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer